Literature DB >> 16219019

Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.

M Venojärvi1, R Puhke, H Hämäläinen, J Marniemi, M Rastas, H Rusko, P Nuutila, O Hänninen, S Aunola.   

Abstract

AIM: The aim of this study was to investigate the role of skeletal muscle fibre type in the regulation of glucose metabolism in middle-aged obese subjects with impaired glucose tolerance (IGT) during a 2-year exercise and dietary intervention.
METHODS: Muscle biopsies (musculus vastus lateralis) were taken from 22 subjects belonging to the intervention group of the Finnish Diabetes Prevention Study [1]. According to their myosin heavy chain (MHC) profile at the baseline, the subjects were divided into two groups: IGT(slow) (n=10) with a high proportion of MHC I isoforms and IGT(fast) (n=12) with a high proportion of MHC II isoforms in the vastus lateralis muscle. The intervention consisted of dietary counselling, strength and power training and/or aerobic exercise. The amount of exercise was the same in both groups; the exercise frequency was 5.1+/-2.7 h/week in the IGT(slow) and 5.1+/-2.8 h/week in the IGT(fast) group.
RESULTS: Fasting glucose (p<0.05), 2-h glucose (p<0.05), fasting insulin (p<0.05), haemoglobin A1c (HbA(1c)) (p<0.01) and insulin resistance (p<0.05) [homeostasis model assessment for insulin resistance (HOMA-IR)] decreased in the IGT(fast) group, whereas only the 2-h glucose and HbA(1c) concentrations decreased in the IGT(slow) group. The amount of the glycogen synthase kinase-3-alphabeta (GSK-3-alphabeta) decreased in the IGT(fast) group (p<0.05). Exercise training increased the lactate dehydrogenase (LDH) (p<0.01), LDH-1 (p<0.05) and citrate synthase (CS) (p<0.05) activities in the vastus lateralis muscle in the IGT(slow) group, but only the CS activity (p<0.05) in the IGT(fast) group.
CONCLUSIONS: The glucose metabolism improved both in the IGT(slow) and IGT(fast) group during the 2-year exercise and dietary intervention. The change was more prominent in the IGT(fast) group than in the IGT(slow) group, associated with the decrease of the GSK-alphabeta protein expression in skeletal muscle. The exercise training improved both glycolytic and oxidative capacity in the vastus lateralis muscle. The glycolytic capacity improved in the IGT(slow) group and the oxidative capacity in both groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219019     DOI: 10.1111/j.1463-1326.2004.00466.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  10 in total

Review 1.  Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism.

Authors:  Barbara Strasser; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sports Med       Date:  2010-05-01       Impact factor: 11.136

2.  Lean and obese Zucker rats exhibit different patterns of p70s6 kinase regulation in the tibialis anterior muscle in response to high-force muscle contraction.

Authors:  Anjaiah Katta; Sunil K Karkala; Miaozong Wu; Sarath Meduru; Devashish H Desai; Kevin M Rice; Eric R Blough
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

3.  Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat.

Authors:  Anjaiah Katta; Sunil Kakarla; Miaozong Wu; Satyanarayana Paturi; Murali K Gadde; Ravikumar Arvapalli; Madhukar Kolli; Kevin M Rice; Eric R Blough
Journal:  Exp Diabetes Res       Date:  2010-03-30

4.  GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

Authors:  T P Ciaraldi; L Carter; S Mudaliar; R R Henry
Journal:  Mol Cell Endocrinol       Date:  2009-06-06       Impact factor: 4.102

5.  Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose tolerance.

Authors:  M Venojärvi; A Korkmaz; S Aunola; K Hällsten; K Virtanen; J Marniemi; J-P Halonen; O Hänninen; P Nuutila; M Atalay
Journal:  Biomed Res Int       Date:  2014-02-04       Impact factor: 3.411

6.  The hypoglycemic mechanism of catalpol involves increased AMPK-mediated mitochondrial biogenesis.

Authors:  Deng-Qiu Xu; Chun-Jie Li; Zhen-Zhou Jiang; Lu Wang; Hong-Fei Huang; Zhi-Jian Li; Li-Xin Sun; Si-Si Fan; Lu-Yong Zhang; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2020-01-14       Impact factor: 6.150

7.  Improved Aerobic Capacity and Adipokine Profile Together with Weight Loss Improve Glycemic Control without Changes in Skeletal Muscle GLUT-4 Gene Expression in Middle-Aged Subjects with Impaired Glucose Tolerance.

Authors:  Mika Venojärvi; Jaana Lindström; Sirkka Aunola; Pirjo Nuutila; Mustafa Atalay
Journal:  Int J Environ Res Public Health       Date:  2022-07-07       Impact factor: 4.614

8.  Diabetes alters contraction-induced mitogen activated protein kinase activation in the rat soleus and plantaris.

Authors:  A Katta; D L Preston; S K Karkala; S Asano; S Meduru; S P Mupparaju; E Yokochi; Kevin M Rice; D H Desai; E R Blough
Journal:  Exp Diabetes Res       Date:  2008

9.  Exercise training with dietary counselling increases mitochondrial chaperone expression in middle-aged subjects with impaired glucose tolerance.

Authors:  Mika Venojärvi; Sirkka Aunola; Raivo Puhke; Jukka Marniemi; Helena Hämäläinen; Jukka-Pekka Halonen; Jaana Lindström; Merja Rastas; Kirsti Hällsten; Pirjo Nuutila; Osmo Hänninen; Mustafa Atalay
Journal:  BMC Endocr Disord       Date:  2008-03-27       Impact factor: 2.763

10.  Graded Resistance Exercise And Type 2 Diabetes in Older adults (The GREAT2DO study): methods and baseline cohort characteristics of a randomized controlled trial.

Authors:  Kylie A Simpson; Yorgi Mavros; Shelley Kay; Jacinda Meiklejohn; Nathan de Vos; Yi Wang; Qianyu Guo; Renru Zhao; Mike Climstein; Bernard T Baune; Steven Blair; Anthony J O'Sullivan; David Simar; Nalin Singh; Maria A Fiatarone Singh
Journal:  Trials       Date:  2015-11-10       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.